Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    flydubai adds Aktau, Atyrau and Tyumen to winter network

    November 21, 2026

    UK and EU agree digital partnership at Brussels summit

    November 21, 2026

    Russian researchers develop heat resistant alloy for flights

    November 20, 2026
    Irish MonitorIrish Monitor
    • Automotive

      Austria electric car registrations jump 63% in October

      November 14, 2026

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      German automaker Porsche extends site guarantees until 2035

      July 28, 2026

      FIA renews push for V8 engines in Formula 1

      July 4, 2026

      Electric car discounts narrow in German market

      May 30, 2026
    • Business

      Euro area annual inflation rises in October as energy jumps

      November 20, 2026

      European gas prices fall 4% to $998 per 1,000 cubic metres

      November 18, 2026

      Gold hovers near one-year low as firm dollar weighs

      November 18, 2026

      Russia’s IT small business sector grows 15% to 256,000 firms

      November 17, 2026

      Italy fines Meta €805 million over Facebook photo access

      November 16, 2026
    • Entertainment

      Generative AI in entertainment advances beyond Affleck’s view

      January 27, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Disney and Marvel’s R-rated film hits billion-dollar milestone

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024

      USHER’s pre-Super Bowl experience on Apple Music

      February 7, 2024
    • Health

      WHO says ending cholera by 2030 is within reach

      November 12, 2026

      Global Impact of 2026 Nobel Medicine Award Highlights Optogenetics Breakthrough

      October 6, 2026

      Global Study from UAE Links Environment and Lifestyle to Accelerated Biological Aging

      October 3, 2026

      WHO Issues Global Heat Risk Guidelines for Mass Gatherings to Safeguard Public Health

      October 2, 2026

      Natural Compound from Pomegranates Shows Promise for Heart Health in UK Research

      October 1, 2026
    • Lifestyle

      Adidas launches You Got This campaign on sideline support

      March 3, 2026

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023
    • Luxury

      Price hikes and lack of innovation erode luxury market confidence

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      UK and EU agree digital partnership at Brussels summit

      November 21, 2026

      European Commission confirms AI-driven cyberattack

      November 20, 2026

      EU tells Andy Burnham no deals unless UK joins single market

      November 19, 2026

      Milburn review seeks reset to get 440,000 young people into work

      November 17, 2026

      EU and Nigeria sign agreement to speed up migrant returns

      November 12, 2026
    • Sports

      IOC and CAS rulings open path for Russia’s sporting return

      November 9, 2026

      Spain knock Portugal out of FIFA World Cup

      July 7, 2026

      Haaland double sends Norway past Brazil in World Cup

      July 6, 2026

      Egypt advance after shootout win over Australia

      July 4, 2026

      Spain advances after 3-0 World Cup win over Austria

      July 3, 2026
    • Technology

      Russian researchers develop heat resistant alloy for flights

      November 20, 2026

      EU launches €525 million platform for chip design start-ups

      November 6, 2026

      Putin allows temporary use of foreign data centres

      November 3, 2026

      Apple iPhone Duo redefines foldables with passport design

      November 2, 2026

      Apple brings OLED and Touch to new MacBook Pro

      October 29, 2026
    • Travel

      flydubai adds Aktau, Atyrau and Tyumen to winter network

      November 21, 2026

      flydubai adds winter flights to Riga, Salzburg and Vilnius

      November 11, 2026

      European Union Sees 1.321 Billion Tourist Nights in Early 2026 Period

      September 3, 2026

      Russia’s International Tourism Gains Momentum Across Major Regions in Early 2026

      September 2, 2026

      Shropshire Extends Free Weekday Bus Travel to Disabled Pass Holders Across the Entire Region

      August 22, 2026
    Irish MonitorIrish Monitor
    Home » Lecanemab could delay Alzheimer’s by over eight years
    Health

    Lecanemab could delay Alzheimer’s by over eight years

    December 7, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    LONDON, December 7, 2025: A new study suggests that lecanemab, an Alzheimer’s drug previously deemed too expensive for use by the National Health Service (NHS), could slow the progression of dementia by up to eight years, far exceeding earlier estimates from clinical trials. Researchers presented the findings at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Diego, revealing that patients who began treatment with lecanemab early in the disease process experienced significantly slower cognitive decline. The drug, also known by its brand name Leqembi and developed by Japanese pharmaceutical company Eisai, targets amyloid protein buildup in the brain, which is believed to play a central role in Alzheimer’s disease progression.

    Lecanemab could delay Alzheimer’s by over eight years
    Scientists present landmark findings in Alzheimer’s clinical trials.

    The National Institute for Health and Care Excellence (NICE) in the United Kingdom had previously ruled that lecanemab’s benefits were not sufficient to justify its high cost, concluding in June that the drug only delayed disease progression by a few months. However, the new analysis indicates that the therapy could extend the period between mild cognitive impairment and moderate Alzheimer’s disease by an average of 8.3 years for patients with low levels of amyloid who begin treatment early. The updated findings also included data on an injectable version of lecanemab designed for at-home use.

    The new formulation, delivered through an auto-injector, could eliminate the need for intravenous infusions typically administered in hospital settings. Researchers said this could make treatment more accessible for patients and reduce pressure on healthcare facilities already managing a rising number of dementia cases. Dr. Richard Oakley, Associate Director of Research and Innovation at Alzheimer’s Society, described the new evidence as a significant step toward improving treatment outcomes for people living with Alzheimer’s disease.

    Study links early treatment to stronger long-term outcomes

    He said that the research demonstrated the potential benefits of starting therapy earlier in the disease course. He added that further analysis is needed to understand how slowing disease progression might affect patients’ ability to remain independent and manage daily activities over time. More than one million people in the UK are currently living with dementia, and approximately one-third are undiagnosed, according to Alzheimer’s Society data. Experts have emphasized that early detection and accurate diagnosis are crucial to ensure patients can benefit from emerging treatments such as lecanemab.

    The new findings have reinforced calls for the NHS to enhance diagnostic capacity, given the growing number of people eligible for such therapies. Although lecanemab is not yet available through the NHS, its potential impact is being closely monitored by health authorities. NHS England estimated last year that introducing new Alzheimer’s treatments could cost between £500 million and £1 billion annually, depending on uptake and delivery methods. The NHS is currently reviewing infrastructure and resources to prepare for the possible rollout of disease-modifying therapies for dementia patients.

    Experts emphasize importance of accurate diagnosis

    Alzheimer’s disease remains the most prevalent form of dementia, accounting for around two-thirds of all cases. It affects memory, thinking, and behavior, gradually impairing a person’s ability to function independently. The Alzheimer’s Society reports that one in three people born in the UK today will develop dementia during their lifetime, and projections indicate that approximately 1.4 million people could be living with the condition by 2040. The findings presented at the San Diego conference mark one of the most promising developments in Alzheimer’s research in recent years.

    While challenges remain over cost and access, the data suggest that earlier and sustained treatment with lecanemab could significantly alter the course of the disease for many patients. As health systems worldwide grapple with an aging population and rising dementia rates, the results have renewed attention on the importance of early diagnosis and investment in effective treatment delivery, highlighting the growing urgency for global collaboration, equitable access, and long-term planning in dementia care. – By EuroWire News Desk.

    Related Posts

    Austria electric car registrations jump 63% in October

    November 14, 2026

    WHO says ending cholera by 2030 is within reach

    November 12, 2026

    IOC and CAS rulings open path for Russia’s sporting return

    November 9, 2026

    MENA Newswire Expands Network with Eurasian Newswire

    October 15, 2026

    Global Impact of 2026 Nobel Medicine Award Highlights Optogenetics Breakthrough

    October 6, 2026

    Global Study from UAE Links Environment and Lifestyle to Accelerated Biological Aging

    October 3, 2026
    Editor's Pick

    flydubai adds Aktau, Atyrau and Tyumen to winter network

    November 21, 2026

    UK and EU agree digital partnership at Brussels summit

    November 21, 2026

    Russian researchers develop heat resistant alloy for flights

    November 20, 2026

    European Commission confirms AI-driven cyberattack

    November 20, 2026

    Euro area annual inflation rises in October as energy jumps

    November 20, 2026

    EU tells Andy Burnham no deals unless UK joins single market

    November 19, 2026

    European gas prices fall 4% to $998 per 1,000 cubic metres

    November 18, 2026

    Gold hovers near one-year low as firm dollar weighs

    November 18, 2026
    © 2024 Irish Monitor | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.